BARX1 and neoplasm: When compared with normal samples, tumor samples showed higher expression of BARX1, ENTPD2, and GFRA3, and lower expression of MYOZ1 and KHDRBS2. The Kaplan–Meier curve with the log-rank test showed that high expression of MYOZ1, KHDRBS2, and GFRA3 indicated a better clinical outcome (Figures 7B–D).